drugset / Trial / NCT01929096
Compound Edaravone Injection for Acute Ischemic Stroke
RandomizedParallel-groupQuadruple-blindTreatment
Summary
1. To investigate the efficacy and safety of multi-doses Compound Edaravone Injection versus Edaravone Injection for acute ischemic stroke patients; 2. To provide evidence for the design of Compound Edaravone Injection Phase III trial.
Timeline
- Start
- 2013-08
- Primary completion
- 2014-12
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Edaravone | Unknown | 30 mg | Intravenous |
| Subject | Edaravone Dexborneol | Unknown | 12.5 mg | Intravenous |
| Subject | Edaravone Dexborneol | Unknown | 37.5 mg | Intravenous |
| Subject | Edaravone Dexborneol | Unknown | 62.5 mg | Intravenous |